000 | 01782 a2200481 4500 | ||
---|---|---|---|
005 | 20250516131942.0 | ||
264 | 0 | _c20130613 | |
008 | 201306s 0 0 eng d | ||
022 | _a1096-9896 | ||
024 | 7 |
_a10.1002/path.4171 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhu, Haifeng | |
245 | 0 | 0 |
_aNPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism. _h[electronic resource] |
260 |
_bThe Journal of pathology _cMay 2013 |
||
300 |
_a82-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCell Adhesion _xphysiology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xphysiology |
650 | 0 | 4 |
_aCell Survival _xphysiology |
650 | 0 | 4 |
_aDown-Regulation _xgenetics |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImines _xpharmacology |
650 | 0 | 4 |
_aLymphoma, T-Cell _xgenetics |
650 | 0 | 4 |
_aMicroRNAs _xgenetics |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xgenetics |
650 | 0 | 4 |
_aSTAT3 Transcription Factor _xgenetics |
650 | 0 | 4 |
_aSignal Transduction _xgenetics |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
650 | 0 | 4 |
_aUp-Regulation _xgenetics |
700 | 1 | _aVishwamitra, Deeksha | |
700 | 1 | _aCurry, Choladda V | |
700 | 1 | _aManshouri, Roxsan | |
700 | 1 | _aDiao, Lixia | |
700 | 1 | _aKhan, Aarish | |
700 | 1 | _aAmin, Hesham M | |
773 | 0 |
_tThe Journal of pathology _gvol. 230 _gno. 1 _gp. 82-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/path.4171 _zAvailable from publisher's website |
999 |
_c22437582 _d22437582 |